Skip to main content
Lobe Sciences Ltd. logo

Lobe Sciences Ltd. — Investor Relations & Filings

Ticker · LOBE CSE Manufacturing
Open in API
Filings indexed 206 across all filing types
Latest filing 2025-02-18 Proxy Solicitation & In…
Country CA Canada
Listing CSE LOBE

About Lobe Sciences Ltd.

https://www.lobesciences.com/

Lobe Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing transformative therapies for rare and underserved diseases with unmet medical needs. The company utilizes innovative technologies, including lipid technology, to advance its pipeline. Through its subsidiary, Cynaptec Pharmaceuticals, Lobe is developing L-130 (Conjugated Psilocin™), a patented formulation engineered to provide the therapeutic effects of psilocybin without the hallucinogenic properties. Its second subsidiary, Altemia, Inc., develops S-100, a novel medical food product intended for the dietary management and treatment of Sickle Cell Disease. The company's research targets conditions such as Chronic Cluster Headache and Sickle Cell Disease.

Recent filings

Filing Released Lang Actions
Other.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a ‘Notice of Availability of Proxy Materials’ for the upcoming Annual and Special Meeting, providing shareholders with instructions on how to access and vote proxy materials. This is a standard proxy solicitation notice rather than the full meeting circular or actual voting results. According to the filing definitions, such communications fall under Proxy Solicitation & Information Statement (PSI).
2025-02-18 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Voting Instruction Form (VIF) used to solicit proxy voting instructions for an upcoming Annual General Meeting, detailing resolutions, proxy appointment, and voting procedures. This is part of proxy solicitation materials rather than the meeting results or the actual Annual Report. It aligns with the definition for Proxy Solicitation & Information Statement (PSI).
2025-02-18 English
Other.pdf
Regulatory Filings Classification · 1% confidence The document is a shareholder request form for receiving the Company’s annual or interim financial statements and corresponding MD&A. It is not the actual financial statements (10-K/IR), not an earnings release, not a proxy or voting result, nor any of the specific categories (e.g., M&A, dividends, share issues). It simply provides instructions for shareholders to request copies, fitting none of the primary report types. Therefore, it falls into the fallback category for miscellaneous regulatory filings.
2025-02-18 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the Form of Proxy for Lobe Sciences Ltd.’s Annual General Meeting, providing voting instructions, resolutions to be approved, proxy appointment details, and notice-and-access information. It is a proxy solicitation document sent to shareholders requesting votes for the AGM, matching the definition of Proxy Solicitation & Information Statement.
2025-02-18 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV2, a Venture Issuer Basic Certificate under National Instrument 52-109 certifying the interim financial report and interim MD&A. It is a regulatory certificate for interim filings, not the interim report itself nor a management discussion, presentation, or earnings release. No specific category matches a certification form, so it falls under the fallback ‘Regulatory Filings’ category.
2025-01-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CEO, which is a compliance certificate under Canadian NI 52-109 for interim financial statements and MD&A. It is not the interim report itself (IR), nor an announcement of its publication (RPA), nor any other specific filing type like MDA, AR, or ER. Therefore it falls into the general regulatory filings category.
2025-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.